Published in J Agric Food Chem on January 28, 2009
Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr (2015) 1.07
Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals? Therap Adv Gastroenterol (2012) 1.01
The Low FODMAP Diet and Its Application in East and Southeast Asia. J Neurogastroenterol Motil (2015) 0.91
Non-coeliac gluten sensitivity: piecing the puzzle together. United European Gastroenterol J (2015) 0.86
Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2015) 0.84
Diet in irritable bowel syndrome. Nutr J (2015) 0.81
The Low FODMAP Diet: Many Question Marks for a Catchy Acronym. Nutrients (2017) 0.78
Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance. Exp Biol Med (Maywood) (2017) 0.76
Perceived food intolerance and irritable bowel syndrome in a population 3 years after a giardiasis-outbreak: a historical cohort study. BMC Gastroenterol (2015) 0.76
Diet, disease activity, and gastrointestinal symptoms in patients with ankylosing spondylitis. Clin Rheumatol (2010) 0.75
Agronomical parameters, sugar profile and antioxidant compounds of "Catherine" peach cultivar influenced by different plum rootstocks. Int J Mol Sci (2014) 0.75
Gastrointestinal Disturbances Associated with the Consumption of Sugar Alcohols with Special Consideration of Xylitol: Scientific Review and Instructions for Dentists and Other Health-Care Professionals. Int J Dent (2016) 0.75
Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome. Exp Ther Med (2016) 0.75
Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review). Int J Mol Med (2017) 0.75
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study. Tech Coloproctol (2017) 0.75
Dietary fiber in irritable bowel syndrome (Review). Int J Mol Med (2017) 0.75
Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol (2011) 5.66
No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology (2013) 4.52
Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol (2008) 3.33
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol (2010) 2.52
The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol (2010) 1.93
Issues associated with the emergence of coeliac disease in the Asia–Pacific region: a working party report of the World Gastroenterology Organization and the Asian Pacific Association of Gastroenterology. J Gastroenterol Hepatol (2014) 1.83
Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol (2010) 1.79
Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust (2010) 1.78
Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc (2006) 1.77
Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol (2012) 1.72
Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr (2012) 1.51
Strategies to manage gastrointestinal symptoms complicating enteral feeding. JPEN J Parenter Enteral Nutr (2008) 1.50
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. Gut (2013) 1.37
Pathogenesis of colonic diverticulosis: repainting the picture. Clin Gastroenterol Hepatol (2013) 1.24
Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol (2013) 1.23
Does butyrate protect from colorectal cancer? J Gastroenterol Hepatol (2006) 1.18
Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis (2008) 1.18
Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: guidelines for clinical approach. J Gastroenterol Hepatol (2006) 1.11
Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.05
Infections and IBD. Nat Clin Pract Gastroenterol Hepatol (2008) 1.04
Fructan and free fructose content of common Australian vegetables and fruit. J Agric Food Chem (2007) 1.03
Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals? Therap Adv Gastroenterol (2012) 1.01
Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol (2006) 1.01
Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World J Gastroenterol (2008) 0.99
Not all effects of a gluten-free diet are due to removal of gluten. Gastroenterology (2013) 0.98
Development and validation of a comprehensive semi-quantitative food frequency questionnaire that includes FODMAP intake and glycemic index. J Am Diet Assoc (2010) 0.97
Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome. Expert Rev Gastroenterol Hepatol (2014) 0.95
Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption. Eur J Gastroenterol Hepatol (2010) 0.94
Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.93
The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders. Nutrition (2010) 0.92
Venous and arterial disease in inflammatory bowel disease. J Gastroenterol Hepatol (2013) 0.90
The influence of specific luminal factors on the colonic epithelium: high-dose butyrate and physical changes suppress early carcinogenic events in rats. Dis Colon Rectum (2005) 0.88
Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflamm Bowel Dis (2007) 0.84
5-Aminosalicylic acid (mesalazine) use in Crohn's disease: a survey of the opinions and practice of Australian gastroenterologists. Inflamm Bowel Dis (2007) 0.83
A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration. J Gastroenterol Hepatol (2007) 0.83
Design of clinical trials evaluating dietary interventions in patients with functional gastrointestinal disorders. Am J Gastroenterol (2013) 0.83
Semiquantitative assessment of breath hydrogen testing. J Gastroenterol Hepatol (2013) 0.82
Endoscopic balloon dilatation of intestinal strictures in Crohn's disease: safe alternative to surgery. J Gastroenterol Hepatol (2007) 0.81
Fructose malabsorption syndrome. Curr Opin Clin Nutr Metab Care (2013) 0.81
Factors associated with physical and cognitive fatigue in patients with Crohn's disease: a cross-sectional and longitudinal study. Inflamm Bowel Dis (2014) 0.81
Colonic epithelial atrophy induced by a fibre-free diet in rats is reversed by minimal amounts of luminal butyrate, but only in the short term. ANZ J Surg (2002) 0.80
The role of thiopurine metabolites in inflammatory bowel disease and rheumatological disorders. Int J Rheum Dis (2014) 0.80
Is gluten a cause of gastrointestinal symptoms in people without celiac disease? Curr Allergy Asthma Rep (2013) 0.79
Fructose and lactose testing. Aust Fam Physician (2012) 0.78
The Low FODMAP Diet for Treatment of Irritable Bowel Syndrome and Other Gastrointestinal Disorders. Gastroenterol Hepatol (N Y) (2013) 0.78
The trophic effect of dietary fibre is not associated with a change in total crypt number in the distal colon of rats. Carcinogenesis (2003) 0.78
Thiopurines, a previously unrecognised cause for fatigue in patients with inflammatory bowel disease. J Crohns Colitis (2009) 0.77
Cytomegalovirus disease, haemophagocytic syndrome, immunosuppression in patients with IBD: 'a cocktail best avoided, not stirred'. J Crohns Colitis (2011) 0.77
Failure of gastroenterologists to apply intestinal ultrasound in inflammatory bowel disease in the Asia-Pacific: a need for action. J Gastroenterol Hepatol (2015) 0.77
Optimizing thiopurine therapy: more weight to the metabolite argument. J Gastroenterol Hepatol (2010) 0.76
For celiac disease, diagnosis is not enough. Clin Gastroenterol Hepatol (2012) 0.75
Response to Comment on low FODMAP diet. Nutr Clin Pract (2013) 0.75
Alternative investigations for irritable bowel syndrome. J Gastroenterol Hepatol (2013) 0.75
Infliximab: getting the most for your money. J Gastroenterol Hepatol (2007) 0.75
Development of a chronic colonic intubation model in rats for the study of luminal factors in colonic diseases. Dis Colon Rectum (2002) 0.75
Comprehensive clinical assessment improves the accuracy of predicting cirrhosis in chronic hepatitis C. J Gastroenterol Hepatol (2005) 0.75